Targeting the PI3K/Akt/mTOR pathway : A therapeutic strategy in COVID-19 patients
Publication date
12/2021Metadata
Show full item recordCitation
Abu Eid , R & Ward , F J 2021 , ' Targeting the PI3K/Akt/mTOR pathway : A therapeutic strategy in COVID-19 patients ' , Immunology Letters , vol. 240 , pp. 1-8 . https://doi.org/10.1016/j.imlet.2021.09.005
Rights
This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/